-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Neutral on Chemours, Lowers Price Target to $14

Benzinga·05/14/2025 14:56:18
Listen to the news
Goldman Sachs analyst Duffy Fischer maintains Chemours (NYSE:CC) with a Neutral and lowers the price target from $21 to $14.